This study aimed to develop a menadione (MD) determination method employing liquid chromatography-tandem mass spectrometry (LC-MS/MS) using a pseudo multiple reaction monitoring (MRM) technique, wherein two quadrupoles are used to monitor the same ion. Detection limits of 40 and 2 pg were obtained for MD and its deuterium-labeled form, respectively, whereas MD intra-and inter-assay coefficient of variation values were determined as 5.4 -8.2%, with the corresponding recoveries equaling 90.5 -109.6%. The developed method enables determination of MD in urine, plasma, cell extract, and culture media, demonstrating that pseudo multiple reaction monitoring can achieve quantification of compounds forming no suitable product ions, such as MD.
Introduction
Phylloquinone (PK, vitamin K1), bearing a phytyl side chain, is converted in vivo into menaquinone-4 (MK-4, vitamin K2), possessing an isoprenyl side chain. 1 Deuterium labeling studies indicate that menadione (MD, vitamin K3), lacking a side chain at the C-3 position, is formed as an intermediate in the conversion of PK to MK-4. Deuterium-labeled MD was detected by high-resolution mass spectrometry in lymph of rats to which deuterium-labeled PK, was orally administered. The PK to MK-4 conversion involves removal of the phytyl side chain to release MD, which is subsequently prenylated with a geranylgeranyl residue, producing MK-4 ( Fig. 1) .
UbiA prenyltransferase domain containing protein 1 (UBIAD1) was identified as the enzyme catalyzing the above prenylation, 3 whereas the major enzyme(s) involved in the cleavage of the PK phytyl side chain remain(s) unidentified. Thus, a full clarification of vitamin K metabolism and disposition, including the determination of enzyme(s) catalyzing side chain cleavage, requires a procedure for MD quantitation. Previously, MD was quantified using several analytical techniques, such as highperformance liquid chromatography (HPLC) with fluorescence detection (HPLC-FL), 4, 5 HPLC with chemiluminescence detection (HPLC-CL), 6 gas chromatography with flame ionization detection (GC-FID), and HPLC with diode array detection (HPLC-DAD). 7 Thijssen et al. 4 measured MD levels in urine samples by HPLC-FL, employing reverse-phase HPLC separation on a C18 column and post-column reduction with Zn. Al Rajabi et al. 5 also quantified urinary MD by HPLC-FL, employing a C30 column and post-column reduction with Zn. Additionally, simultaneous determination of MD and its thioether conjugates in rat plasma by HPLC-CL was reported, 6 whereas concentrations of MD and its analogues in pharmaceutical preparations were also determined by GC-FID and HPLC-DAD. 7 However, those methods are not applicable for stable radioisotope-labeled compounds, which is necessary for studies of vitamin K metabolism. Therefore, development of a method for determination of MD using mass spectrometry (LC-MS) or tandem mass spectrometry (LC-MS/MS) is expected.
LC-MS/MS analysis using multiple reaction monitoring (MRM) is usually performed using triple-quadrupole mass spectrometers, with precursor ions being isolated in the first quadrupole and fragmented in the second one (which acts as a collision cell), while characteristic product ions are selected in the third quadrupole. MRM exhibits the advantages of high sensitivity and accuracy, being well suited for the determination of vitamin K derivatives bearing side chains, including PK and MK-4. 8 MD is unlikely to produce stable MRM-suitable fragments, since it lacks a side chain. In addition, due to the low molecular weight of MD (Mw = 172.18), its product ions generated at high collision energies exhibit comparatively small m/z values, resulting in non-specific signals with a high background noise level. Successful determination of MD based on LC-MS/MS can be performed by quantifying the levels of MK-4 generated in the enzymatic reaction of recombinant human UBIAD1 with deuterium-labeled geranylgeranyl pyrophosphate (GGPP). 2 Moreover, Liu et al. 9 recently reported an LC-MS/MS method for determination of MD relying on derivatization with 3-mercaptopropionic acid via Michael addition. The above methods for determination of MD are effective but complicated, necessitating the development of a novel facile analytical procedure.
In this report, we propose a simple and useful method for determination of MD based on pseudo MRM. Pseudo MRM is a technique where mass filters of the first quadrupole and the third quadrupole monitor for the same molecular ion and are employed for quantitation. In pseudo MRM, the target ions are selectively transferred to the third resolving quadrupole mass filter without collision induced dissociation. Figure 2 shows a schematic diagram of pseudo MRM in quantitation of MD.
Experimental
Chemicals and reagents MD was purchased from Nacalai Tesque, Inc. (Kyoto, Japan). MD-d3, of which three hydrogen atoms of the methyl group at C-2 position are replaced by deuterium, and MD-d8, of which all eight hydrogen atoms are replaced by deuterium, were provided by C/D/N Isotopes, Inc. (Quebec, Canada). PK-d3 and MK-4-d3, of which three hydrogen atoms of the methyl group at C-2 position are replaced by deuterium, were synthesized by our group. The chemical structures of MD-d3, MD-d8, PK-d3 and MK-4-d3 are shown in Fig. S1 (Supporting Information). HPLC-grade solvents were purchased from Nacalai Tesque, Inc.
Cell culture
The human hepatoblastoma cell line (HepG2), human colon adenocartinoma cell line (Caco-2), and porcine kidney cell line (LLC-PK1) were obtained from the American Type Culture Collection (ATCC, Manassas, VA). The rat small intestine epithelial cell line (IEC-6) was obtained from Riken Cell Bank (Ibaragi, Japan). The human kidney proximal tubule cell line (CL-8) was kindly gifted by Dr. E. Takeda, Tokushima University, Japan. HepG2 cells were maintained in minimum essential medium (MEM) containing 10% fetal calf serum (FCS), 1% non-essential amino acids, and 1% sodium pyruvate. Caco-2 cells were maintained in MEM containing 10% FCS and 1% non-essential amino acids. LLC-PK1 cells were maintained in Medium 199 containing 5% FCS. IEC-6 cells were maintained in Dulbecco's modified Eagle's medium (DMEM) containing 5% FCS and 4 μg/mL insulin. CL-8 cells were maintained in DMEM/Ham's F-12 medium (1:1) containing 5% FCS. Cells were cultured at 37 C in a humidified atmosphere of 5% CO2 with a change of medium every 3 days. Cells were incubated with 10 -5 M PK-d3 for 24 h, followed by extraction of MD-d3 and MK-4-d3 in the cells and culture media.
Extraction of MD and MK-4
For extraction of MD, urine (0.5 mL), plasma (0.5 mL), and cultured cell and media (1 -5 mL) samples containing internal standard (MD-d8, 2.5 ng) were extracted twice with diethyl ether of four times of the sample volume. The diethyl ether extract added to 50 μL of 50% ethylene glycol was evaporated using a gentle stream of nitrogen until 50 μL of 50% ethylene glycol was left, and 50 μL of methanol was added to the residue, representing a modification of a previously described method. 4 To hydrolyze MD conjugates, samples were treated with a sulfuric acid/dichromate mixture prior to extraction, as described previously. 4 For extraction of MK-4, cultured cell and media (1 -5 mL) samples were extracted twice with hexane of six times of the sample volume, representing a modification of a previously described method. 8 
Measurements of MD and MK-4
The employed HPLC system consisted of an SCL-10ADvp system controller, two LC-10ADvp pumps, a DGG-14A automatic solvent degasser, an SIL-10ADvp automatic injector, and a CTO-10ADvp column oven held at 35 C (Shimadzu, Kyoto, Japan). The HPLC system was coupled to an API 3000 triple-quadrupole tandem mass spectrometer (Applied Biosystems/MDS SCIEX, Foster City, CA, USA) equipped with an atmospheric pressure chemical ionization (APCI) source, and Analyst software (Ver. 1.4.2; Applied Biosystems/MDS SCIEX) was used for data acquisition and analysis. Separations were performed on a Capcellpak C18 UG120 column (4.6 mm i.d. × 250 mm, 5 μm, Shiseido Co., Ltd., Tokyo, Japan), and a 15-min linear gradient of 45 to 90% aqueous methanol was used for quantifying MD and its deuterium-labeled counterpart. A flow rate of 1.0 mL/min was used, with the injection volumes of standard and sample solutions being equal to 40 μL. The mass spectrometer was operated in negative-ion mode. -6 V). Curtain gas, nebulizer gas, and collision gas pressures (8, 8 , and 4 psi, respectively), as well as nebulizer current (-4 μA) and ion source temperature (400 C) were identical for all experiments. The concentration of MK-4-d3 was measured using LC-APCI-MS/MS in the positive-ion mode according to a previously reported method.
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Results and Discussion
Pseudo MRM exhibited high sensitivity comparable to that of HPLC-FL, with no crosstalk interference between non-labeled and deuterium-labeled MD observed.
Furthermore, the advantages of pseudo MRM over single-ion monitoring (SIM) were clearly demonstrated in terms of signal to noise (S/N) ratio with the lower noise level and higher signal intensity (Fig. 3) . The linearity of MD and MD-d3 calibration curves was confirmed for up to 50 ng per injection. Figure S2 (Supporting Information) shows MRM chromatograms for determination of MD in pooled human urine and rat plasma. Since MD was detected only in the samples with hydrolyzing treatment (Figs. S2c and S2d, Supporting Information), we conclude that MD was mainly present in the form of conjugates, such as glucuronides and sulfates, as described elsewhere.
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The detection limits of MD, MD-d3, and MD-d8 (defined as S/N = 3) equaled 40, 2, and 2 pg per injection, respectively, revealing a higher sensitivity for deuterium-labeled MD than for unlabeled MD. Intra-and inter-assay coefficient of variation (CV) values of 5.4 -8.2% were obtained for pooled urine samples containing low or high MD concentrations (Table 1) , with the recoveries for samples spiked with 1 or 5 ng of MD before or after hydrolysis equaling 90.5 -109.6%.
As a next step, we tried to detect MD-d3 and MK-4-d3 produced from PK-d3 in cultured cells derived from the gastrointestinal tract because production of MD from PK is thought to occur during the course of intestinal absorption. MD-d3 generated from PK-d3 was detected in cells and culture media after hydrolyzing treatment (Figs. 4a, 4c and S3a, Supporting Information). A small amount of MD-d3 was detected in culture media, but not in cell extract, without hydrolyzing treatment (data not shown), suggesting produced MD-d3 was mostly conjugated. In addition, MK-4-d3 generated from PK-d3 was detected in cells and culture media obtained in the same experiment (Figs. 4b, 4d and S3b, Supporting Information). The production of MD-d3 and MK-4-d3 from PK-d3 in HepG2, Caco-2, IEC-6, CL-8 and LLC-PK1 cells is shown in Fig. S3 (Supporting Information) . In all tested cell lines, MD-d3 derived from PK-d3 was detected in cells and culture media with hydrolyzing treatment (Fig. S3a, Supporting  Information) .
MK-4-d3 was also produced from PK-d3 (Fig. S3b, Supporting Information) . MD-d3 was mainly detected in culture media for all tested cell lines, while MK-4-d3 was detected in both cells and culture media. MD is known to induce production of reactive oxygen species and exert cytotoxicity. 12 Therefore, MD is assumed to be metabolized into menadiol, a hydroquinone form of MD, and conjugated with glucuronides or sulfates for elimination from cells to media as detoxification.
Understanding of the metabolism, distribution and mobilization of MD has been a missing stroke in the research of vitamin K. Its poor producibility of fragmented ions suitable for MRM analysis has prevented us from determining the precise concentration of MD in biological samples. However, it is important to determine MD to understand the whole picture of vitamin K biology, because it is a critical mediator of the metabolism of PK to MK-4, an active form of vitamin K, and on the other hand it is cytotoxic. 12 In this manuscript, we have applied pseudo MRM LC-MS/MS for the determination of MD in biological samples and obtained satisfactory precision and accuracy. This finding opens a novel window to examine metabolism of vitamin K in vivo.
Recently developed pseudo MRM method provided better sensitivity than SIM in the determination of MD (Fig. 3) . The superiority of pseudo MRM over SIM has been conspicuous on structurally stable compounds, like MD. Shang et al. applied pseudo MRM to the determination of polycyclic aromatic hydrocarbons and explained the reason as follows: in pseudo MRM, contaminated less stable isobaric interfering compounds, but not objective stable compounds, are selectively fragmented in the collision cell to reduce signal noise, resulting in a low S/N ratio. 13 Although conventional MRM also has better sensitivity than SIM, MD does not produce fragmented ions suitable for MRM, which prevented us from determining MD by conventional MRM. A smilar limitation has been reported regarding valproic acid, a small molecule antiepileptic agent, and its metabolite. [14] [15] [16] [17] [18] [19] Thus, pseudo MRM would be a useful for determining small stable compounds producing no fragmented ions suitable for conventional MRM.
Pseudo MRM is an effective tool to determine various molecules, especially in biological samples, because pseudo MRM provides a good S/N ratio even with many contaminated molecules as described above. Zhu et al. examined pharmacodynamics of HS061, a human insulin analogue with M.W. 66251, and detected nanogram levels of HS061 in plasma. 20 Concentrations of large proteins in biological samples, such as tissue inhibitor of metalloproteinase 1 (TIMP1) and tissue-type protein tyrosine phosphatase kappa (PTPk) in human serum 21 and uromodulin in human urine, 22 have also been determined by pseudo MRM with tryptic digestion. Aromatic hydrocarbons also take the advantages of pseudo MRM. 13 Thus, pseudo MRM is useful for both large and small molecules, especially for molecules that do not produce fragment ions in a collision cell. We here demonstrated that MD in biological samples can also be determined by pseudo MRM and filled a missing link in vitamin K research. Further applications of pseudo MRM for determination of various endogenous biological molecules producing no MRM-suitable fragment ions will be expected.
